Summary.-The results of a series of mouse-skin paintings are given for fractions prepared by two schemes designed to concentrate the polycyclic aromatic hydrocarbons (PAH) and their heterocyclic analogues (HETC) present in cigarette smoke condensate into single fractions. It is demonstrated that, for each group, a single index of tumour response, the " Weibull risk parameter " (WRP), can be calculated which, considered in conjunction with two other parameters common to all the groups, adequately describes the pattern of tumour incidence in that group. These indices can be used to calculate for each fraction a further statistic, the " tumorigenic ratio " (TR), which conveniently measures the activity of the fraction relative to wholesmoke condensate on a weight-for-weight basis. From the analyses it is shown that the separation processes can successfully concentrate all types of mouse-skin carcinogenic material, irrespective of the type of condensate used, and that a combination of processes prepares an active concentrate representing 2% by weight of the original condensate.
THE complete carcinogenis for mouse skin (substances which produce skin tumours when tested alone) that have been chemically identified in cigarette smoke fall into two chemically related groups: the polveyclic aromatic hydrocarbons (PAH) and their heterocyclic analogues (HETC) in particular the Nheterocyclic compounds (Wvnder and Hoffman, 1959, 1968; Hoffmann and Wynder, 1966) . Wlhitehead and Rothwell (1969) described a number of solvent partition methods in which the PAH and HETC constituents of smoke could be concentrated into single fractions. They showed that virtually all the carcinogenic components of whole-smoke condensate are insoluble in water (Fraction C) and can substantially be extracted from aqueous methanol solution by cyclohexane. This cyclohexane fraction (Fraction (G, Figs. 1 and 2) has been used as the starting material for attempts to isolate further the components of smoke condensate carcinogenic to mouse skin. This paper gives the results of mouse skin bioassays of fractions prepared from Fraction G( using two bilateral solvent-distribution procedures.
The first procedure (XVhitehead and Rothwell, 1]969) used the solvent pair cyclohexane and dimethyl sulphoxide, resulting in the fractions K(G) and L(G). The second procedure was based on work by Rothwell and WThitehead (1969), who showed that many N-heterocyclic aromatic substances could be extracted from cyclohexane solution by aqueous formic acid (90%0 w/v) . This procedure resulted in two fractions; R(G), which contains basic heterocyclic compounds together with other formic-acid-soluble substances, and P(G), which contains all the PAH of Fraction G, together with other substances which form complexes with caffeine.
MATERIALS AND METHODS

Preparation of condensates
Cigars (Cl, C3 Smoking procedures.-The automatic smoking machine described by Day (1967) was used for smoking all these products, a separate smoking disc furnished with appropriately sized holders being fitted for cigar smoking. The same smoking parameters were used as given by Davies and Day (1969) .
Non-volatile whole smoke condensate (NVWSC).-Whole smoke condensate was collected, checked for non-volatile whole smoke yield by determination of nicotine, and the solvent evaporated for the preparation of NVWSC, using the methods described by Davies and Day (1969) .
Stored condensate (SWS).-NVWSC collected over 4 weeks was combined and stored at -29°C for a further 4 weeks before use.
Solvents.-All solvents were purified by the method described by Whitehead and Rothwell (1969) .
Preparation of fractions
Fractionation Scheme 1 ( Fig. 1 ; after Whitehead and Rothwell, 1969) Stages 1 and 2. Fractions B, C, F and G were prepared from SWS by removal of the water-soluble materials (Fraction B) and subsequent distribution of the water-soluble residue (Fraction C) between 90% v/v aqueous methanol (Fraction F) and cyclohexane (Fraction G). Stages 1 and 2. Fractions B, C, F and G were prepared as in Scheme 1.
Stage 3 (Scheme 2a) Fractions Q(G) and (R + P)G. Fraction G (10 g) dissolved in cyclohexane (100 ml) was extracted 8 x with a solution of caffeine (15% w/v) in aqueous 90% formic acid (8 x 30 ml). The cyclohexane phase was washed with water (2 x 30 ml) and Fraction Q(G) was recovered by evaporation of the solvent. The formic acid phase was diluted to 2 1 with water, extracted with benzene (3 x 100 ml), neutralized with caustic soda, and again extracted with benzene (3 x 100 ml). Fraction (R + P)G remained after washing the benzene extracts and removing the solvent under reduced pressure.
Stage 3 (Scheme 2b) Fractions R(G) and S(G). Fraction G (10 g) dissolved in cyclohexane (100 ml) was extracted 4 x with aqueous 90% formic acid (50; 30; 20; 20 ml).
The cyclohexane phase was washed with water (2 x 30 ml) and Fraction S(G) was recovered by evaporation of the solvent. Fraction R(G) was recovered from the formic acid phase by dilution, neutralization and benzene extraction as detailed above for (R + P)G.
Stage 4 (Scheme 2b) Fractions P(SG) and Q(SG). Fraction S(G) (from 10 g G) dissolved in cyclohexane (100 ml) was extracted 8 x with a solution of caffeine (15% w/v) in aqueous 90% formic acid (8 X 20 ml). Fraction Q(SG) was isolated from the cyclohexane phase, and P(SG) was isolated from the formic acid phase, by the methods described above. Solvents.-Exps. 1, 3, 8 and 9, all the smoke condensates and fractions were dissolved in acetone-water: 9/1. In Exps. 4, 5, 6, 7 and 10, the solvent used was acetoneisopropanol: 4/1. In Exp. 2 the smoke condensate tested was dissolved in acetonewater: 9/1 and the fraction tested, G, in acetone-petroleum ether: 7/3. Skin tumours.-Skin tumours in the treated area were recorded by visual inspection. The week of skin tumour was taken as the week it was first observed on the living mouse, whether or not it later regressed or became malignant.
Histological preparations were examined for all skin tumours in the treated area, and the criterion of malignancy was penetration of the muscle fibres ofthe panniculus carnosus. Mice satisfying this criterion were said to have an infiltrating skin carcinoma, and the week of infiltrating skin carcinoma was taken as the week of death of the animal.
In non-life-time experiments some extra skin tumours and infiltrating skin carcinomas were recorded at the week of termination, in the first case because a special search was carried out just before the mice were killed, and in the second case because microscopy revealed carcinomas which would otherwise not have been found until a later date. In order to avoid bias, these results were ignored, and the experiment effectively considered only up to the week before termination.
Statistical methods
Weibull risk parameter (WRP ).-Separate analyses were carried out for skintumour-bearing animals (TBA) and infiltrating skin carcinomas (CBA). The response in each treatment group was measured by the " Weibull risk parameter " (WRP). The definition of this parameter, the method of calculation of it that was used, and justifications for its validity as a tumour index are given in the Statistical Appendix. The parameter measures relative incidence in the sense that, at any instant of time, a tumourfree mouse in a treatment with WRP of b1 has bl/b2 times the probability of getting a tumour than has a tumour-free mouse in a treatment with parameter b2. Use of the WRP enables a proper comparison of the carcinogenic effect of each treatment to be made, unbiassed by any systematic differences in non-tumour mortality between groups.
Tumorigenic ratio (TR).-The relative activity, on a weight-for-weight basis, of particular pairs of fractions tested (or of a fraction and SWS) was measured by the " tumorigenic ratio " (TR). The TR is the inverse of the ratio of doses of the 2 fractions required to produce the same response. For example a TR of 0-83 for the ratio of G to SWS implies that 83 mg of SWS is estimated to yield the same tumour response as 100 mg (equivalent dose) of G. If the tumour-producing components of SWS act independently, this value of 0-83 can also be taken to mean that 83% of these components lie in fraction G. The method of calculation of TR and the justification for its use are given in the Statistical Appendix.
RESULTS
The results from the series of experiments are summarized in Tables II-VIII.  Each table is (Table II ).-The results confirmed earlier work which showed that virtually all the active materials of whole smoke condensate leading to the production of skin tumours and the further development of infiltrating carcinoma are insoluble in water and can be concentrated into Fraction C.
Stage 2 (Table III ) Stage 3 (Table IV ).-The results showed that, if Fraction G is distributed between cyclohexane and dimethyl sulphoxide (DMSO), the material recovered from the DMSO (Fraction L(G) representing 7 5 % w/w of the original whole smoke condensate) contains slightly more activity than Fraction G in the production of both tumours and carcinomas. The material retained in the cyclohexane, Fraction K(G), proved to be of low carcinogenicity. The test on the recombined fractions K(G) + L(G) showed no significant reduction in activity below the original Fraction G. Fractionation Scheme 2 (Fig. 2) Stage 3 (Table V ) .-The material extracted from Fraction G with a formic acid solution of caffeine, Fraction (R + P)G, was shown to have virtually the same activity as Fraction G, both for TBA and CBA. If the separation is carried out in two stages, to produce Fractions R(G) and P(SG), some small loss of activity may occur, as indicated in the results of the tests using the recombined material R(G) + P(SG), though no individual TR was significantly less than unity. The efficiency of the separation procedure for extracting the tumour-producing substances of smoke condensate into Fraction (R + P)G or (Table V) or flue-cured cigarettes treated with sodium nitrate (Table VI-T56 ). The loss of activity in the preparation of R(G) + P(SG) from Fraction G is statistically significant when condensate from small cigars is used (Table VI) SWS-*C--+G--*L(G) or SWS-4C--4G-*(R + P)G or R(G) + P(SG) successfully concentrate a high proportion of the tumour-and carcinoma-producing substances of whole smoke condensate -into fractions representing progressively lower percentages by weight of the original smoke material. Only small tumorigenic activity could be detected in fractions other than the above. Thus, although the final fraction (R + P)LG has not been tested, it seems likelv that a combination ofthe two separation schemes, using the sequence:
SWS
LG would achieve a concentration of the carcinogenic material of smoke condensate into a fraction representing under 2% by weight of the original condensate. Mouse skin bioassay of the subfractions separately at each stage showed an active fraction and a fraction with little or no tumorigenic activity. Also, the checks on the activity of the recombined fractions demonstrate that any reduction in tumorigenicity of the active fraction is due to mechanical losses rather than to a separation of co-carcinogens into the fraction giving no tumours when tested alone. Whitehead and Lee (unpub.) show in a separate paper that Stage 4 of Fractionation Scheme 2a (Fig. 2) on Fraction (R + P)G produces two fractions R(G) and P(G), and that these fractions contain materials of different carcinogenic type. Assuming a multistage hypothesis for carcinogenesis (Armitage and Doll, 1954) , the best fitting model to the results of these mouse skin tests was one in whch both fractions affected one stage of the carcinogenic process and fraction P(G) also affected another stage but to a lesser degree. This result would be consistent with the activity of Fraction P being due to complete carcinogens (i.e. PAH) with that of Fraction R being due to small amounts of initiating substances boosted substantially by co-carcinogens.
The tests described in this paper have demonstrated that all the mouse skin carcinogens of whole smoke condensate can be substantially concentrated into Fraction (R + P)G, irrespective of the type of condensate used. However, a further separation of these subfractions is needed to explain differences in activity between different condensates. The testing of Fractions R and P from condensate from cigars, standard flue-cured cigarettes and nitratetreated flue-cured cigarettes suggests that the difference in activity of their condensates, and of their fractions (R + P)G, is due to the presence of different proportions of the two types of incomplete carcinogen.
The conclusions obtained in this paper have been based on fitting to all 55 treatment groups a distribution of time to tumour that is identical apart from one parameter, the WRP. Although, as shown in the Statistical Appendix, there is evidence that this fit is significantly imperfect, it is in practice extremely good for such a large amount of data. This finding, anid the fact that all tumorigenic ratios have been based on comparisons ( When assessing the relative activity of two different fractions (or of the same fractions from two different materials) it is useful to be able to do this on a weightfor-weight basis. However, for one to be able to say validly that a given weight of Fraction X produces an equivalent tumour response to T x that weight of Fraction Y (a TR of X/Y of T) for any given weight, it is necessary that the shape of the relationships between response and the log dose for the two fractions compared be parallel. Furthermore, it is convenient if the response variable can be chosen so that this relationship is linear. As there are theoretical reasons for expecting b (and therefore WRP) to be proportional to a power of dose (Peto and Lee, 1973) , choice of log b as a response measurement was indicated, and Weibull mutiple regression analysis (ibid.) was therefore carried out to test the adequacy of the hypothesis that the relationship between log b and log dose was linear and parallel for every treatment. In this analysis, the parameters of the following models were estimated: whereV qU (t2 -t1), U log T and the variances and covariances of q, t1 and t2were obtained (asymptotically) from the multiple regression equations. Linearity of log dose-response relationship
As noted in the discussion there are a priori reasons based on the findings of Davies et al. (1974) why the linear relationship assumed between log dose and log b (or log WRP) might not hold at the highest dose levels tested. The detailed results of the multiple regression analysis were therefore examined to see where departures from the assumption occurred.
The main misfit occurred in SWS (C3) (see Table VIII ) where the dose response was relatively steeper than that for other materials. The response at 65 mg was particularly low compared with that expected. The dose response for (R + P)G (T29) (see Table V ) was also steeper that expected. For CBA, the main misfit was for C (T29) (see Table II) where the dose response was shallower than expected. However there was no 
